Platform
Features
0 followers
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Industries
Headquarters
Employees
Links
Ben Bergo
9 members
8 members
5 members
4 members
3 members
Cargo
1 follower
Apogee Therapeutics
Imvax
Elektrofi
Cellares
2 followers
Thermo Fisher Scientific
148 followers
Genentech
144 followers
Gilead Sciences
121 followers
Biogen
108 followers
Regeneron
89 followers
Akari Therapeutics
Discover companies